Th2 polarization facilitates S. aureus binding and colonization, and IL-4 and IL-13 inhibit skin production of AMPs, predisposing atopic dermatitis skin to S. aureus infections, which, in turn, further exacerbates skin inflammation and barrier defects. Here, IL13 is linked to atopic eczema.